NCT07482293 (OHIP) is a NA clinical trial of OHIP in Oral Health Related Quality of Life (OHRQoL), sponsored by University Hospital, Clermont-Ferrand.

Who is sponsoring NCT07482293?

NCT07482293 is sponsored by University Hospital, Clermont-Ferrand.

What drugs are being tested in NCT07482293?

Interventions in NCT07482293: OHIP.

What condition does NCT07482293 study?

NCT07482293 studies Oral Health Related Quality of Life (OHRQoL).

Is NCT07482293 still recruiting?

NCT07482293 is currently completed. Last updated 24 March 2026.

Last reviewed 2026-03-24 · How we verify

NCT07482293: OHIP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of a French Version of the OHIP - Oral Health Impact Profile

Completed NA Last updated 24 March 2026

What this trial tests

NA trial testing OHIP in Oral Health Related Quality of Life (OHRQoL) in 200 participants. Completed in 28 November 2025.

Timeline

13 January 2025

Primary endpoint
28 November 2025

28 November 2025

Quick facts

Lead sponsor	University Hospital, Clermont-Ferrand
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	200
Start date	13 January 2025
Primary completion	28 November 2025
Estimated completion	28 November 2025
Sites	1 location across France

Drugs / interventions tested

OHIP

Conditions studied

Oral Health Related Quality of Life (OHRQoL) — all drugs for Oral Health Related Quality of Life (OHRQoL) →

Sponsor

University Hospital, Clermont-Ferrand

Who can join

18 and older, any sex, with Oral Health Related Quality of Life (OHRQoL). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is therefore to propose and validate a French-language (France) version of the OHIP (49 questions) (OHIP-fr-49: long version), and the secondary objective is to validate a shortened version, OHIP-fr-14.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

NCT07179276 — Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock · NA · recruiting
NCT07476768 — PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study · NA · not yet recruiting
NCT07439146 — Risk of Pneumonia in Intubated Patients in Emergency Situations · not yet recruiting
NCT07427537 — Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients · NA · recruiting
NCT07330856 — Evaluation of Treatments for Dry or Productive Cough · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07482293 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Clermont-Ferrand
Last refreshed: 24 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07482293.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing